Literature DB >> 21851974

Effects of education on harm-reduction programmes.

Shu-Yu Lyu1, Lien-Wen Su, Yi-Ming Arthur Chen.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21851974      PMCID: PMC7137150          DOI: 10.1016/S0140-6736(11)60786-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
Harm-reduction programmes are remarkably successful in controlling HIV in injecting drug users worldwide, but more effort is needed to prevent even more HIV infections in this group. Recent reviews2, 3, 4 of the evidence on HIV in injecting drug users focused on risk environment, individual behavioural approaches, and medical treatment and care. Still, little is known about evidence-based educational intervention effects of harm-reduction programmes for injecting drug users. The HIV epidemic in injecting drug users in Asia began in the late 1980s. Affected countries included Thailand, India, Burma, China, Vietnam, Nepal, and Indonesia. From the early 2000s, HIV infection emerged in Taiwanese injecting drug users. The HIV seroincidence increased dramatically in the aftermath of the severe acute respiratory syndrome (SARS) pandemic in 2003, particularly in injecting drug users: new HIV cases peaked in 2005.6, 7 As of April 30, 2011, a cumulative total of 20 638 Taiwanese have been infected with HIV since 1984 in a current population of 23 million. The major HIV risk factors for Taiwanese injecting drug users have been the reuse of drug paraphernalia and the sharing of dissolved heroin solution, which both increased as a result of a perceived decrease in the drug supply when air travellers from China faced possible quarantine during the SARS outbreak. The harm-reduction programmes in Taiwan consist of three main components: information, education, and communication; a syringe-exchange programme; and a drug-substitution treatment programme that includes methadone-maintenance treatment as its central feature. The programmes began operating in November, 2005, and resulted in a decline in the number of injecting drug users newly infected with HIV.5, 6 The personnel in syringe-exchange programmes for dispensing and providing education services are an important element. Another study found that the positive HIV-antibody rates in returned syringes halved, from 18·0% in March, 2007 to 9·4% in October, 2007. Furthermore, the effect of methadone-maintenance treatment on the number of drug-related offences was striking. After methadone-maintenance treatment services expanded into a nationwide programme in August, 2006, the number of participants reached a plateau in November, 2008. Subsequently, the number of criminal arrestees using heroin (a schedule-I drug) in Taiwan fell below the number of criminal arrestees using schedule-II drugs (metamfetamine, methylenedioxymetamfetamine [MDMA], and marijuana) for the first time in August, 2009 and the trend has continued since (figure ).
Figure

Effectiveness of AIDS education and harm-reduction programmes in Taiwan

Data on new HIV-1-infected injecting drug users and cumulative numbers of patients enrolled in methadone-maintenance clinics are from Taiwan Centers for Disease Control. Data for schedule-I criminal arrestees (heroin users) and schedule-II criminal arrestees (metamfetamine, methylenedioxymetamfetamine [MDMA], or marijuana users) are from Taiwan's Ministry of Justice. A pilot programme was done in two cities and two counties, from November, 2005, to July, 2006.

Effectiveness of AIDS education and harm-reduction programmes in Taiwan Data on new HIV-1-infected injecting drug users and cumulative numbers of patients enrolled in methadone-maintenance clinics are from Taiwan Centers for Disease Control. Data for schedule-I criminal arrestees (heroin users) and schedule-II criminal arrestees (metamfetamine, methylenedioxymetamfetamine [MDMA], or marijuana users) are from Taiwan's Ministry of Justice. A pilot programme was done in two cities and two counties, from November, 2005, to July, 2006. However, the decrease in the number of newly HIV-infected injecting drug users began before implementation of the harm-reduction programmes by the government (figure). According to monthly reports of new HIV-1 infections in injecting drug users and the numbers of participants in methadone-maintenance treatment, the peak (252 cases) of reported HIV-1 cases occurred in June, 2005, followed by a decreasing trend.7, 12 The pilot harm-reduction programmes were launched only in two cities and two counties in November, 2005 with limited access to methadone-maintenance treatment.5, 6 Retrospectively, we note that Taiwan's non-governmental organisations have conducted outreach HIV-prevention education for different vulnerable groups since the early 1990s.5, 6 Subsequently, the rapid rise in cases during the HIV epidemic garnered media attention and reporting. A project of Taiwan's Society of Preventive Medicine's Living with Hope Organization started HIV/AIDS-related group education for illegal drug-using arrestees in detention centres and prisons in November, 2004, when alarming signs of outbreaks of HIV-1 infection in injecting drug users appeared. Previous education focused only on the risk of sharing needles or syringes rather than dissolved heroin solution; hence, one focus of the education was to correct the unintended implicit message that sharing drug solutions is risk free. Later, this correction was widely disseminated by the Taiwanese Centers for Disease Control during the harm-reduction programmes. Some injecting drug users reported that the only risk factor for contracting HIV was sharing the dissolved heroin solution.8, 9 Although complex, Taiwan can best be characterised as having a mixed, concurrent HIV-1 epidemic. Since 2007, the explosive HIV-1 epidemic in Taiwan in injecting drug users has become largely controlled with the implementation of harm-reduction programmes (figure). However, a surge in the epidemic subsequently emerged, raising alarm that gains could easily be lost and that the transmission pattern was shifting into the more generalised population. Our research and that of others soon revealed that a major driver of this emerging pattern was transmission via men having sex with men. The number of men having sex with men newly infected with HIV had steadily increased from 571 (17% of all new cases) in 2005 to 1275 (71%) in 2010. Taiwan's experience illustrates how a misplaced emphasis on an emerging epidemic in one risk group can lead to relative neglect of another risk group to produce an unexpected increase in the HIV-1 epidemic. Therefore there is an urgent need to address the psychosocial, behavioural, and other related factors that might play important roles in driving the Taiwanese HIV-1 epidemic in men having sex with men and their wider social or peer networks. Developing a culturally appropriate educational approach for this group has become a new challenge for governmental and non-governmental organisations in Taiwan.
  8 in total

1.  Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed.

Authors:  Louisa Degenhardt; Bradley Mathers; Peter Vickerman; Tim Rhodes; Carl Latkin; Matt Hickman
Journal:  Lancet       Date:  2010-07-24       Impact factor: 79.321

2.  HIV-1 in Taiwan.

Authors:  Yi-Ming Arthur Chen; Steve Hsu-Sung Kuo
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

3.  Role of Service Providers of Needle Syringe Program in Preventing HIV/AIDS.

Authors:  Tzu-I Tsai; Donald E Morisky; Yi-Ming A Chen
Journal:  AIDS Educ Prev       Date:  2010-12

Review 4.  Time to act: a call for comprehensive responses to HIV in people who use drugs.

Authors:  Chris Beyrer; Kasia Malinowska-Sempruch; Adeeba Kamarulzaman; Michel Kazatchkine; Michel Sidibe; Steffanie A Strathdee
Journal:  Lancet       Date:  2010-08-14       Impact factor: 79.321

5.  HIV and risk environment for injecting drug users: the past, present, and future.

Authors:  Steffanie A Strathdee; Timothy B Hallett; Natalia Bobrova; Tim Rhodes; Robert Booth; Reychad Abdool; Catherine A Hankins
Journal:  Lancet       Date:  2010-07-24       Impact factor: 79.321

Review 6.  Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.

Authors:  Daniel Wolfe; M Patrizia Carrieri; Donald Shepard
Journal:  Lancet       Date:  2010-07-31       Impact factor: 79.321

7.  Molecular epidemiology of HIV-1 subtype B, CRF01_AE, and CRF07_BC infection among injection drug users in Taiwan.

Authors:  Yen-Ju Chen; Yu-Huei Huang; Shao-Yuan Chuang; Diana Yu-Ting Kao; Yu-Ching Lan; Jyh-Yuan Yang; Yi-Ming Arthur Chen
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04-01       Impact factor: 3.731

8.  The Role of Nonformal Education in Combating the HIV Epidemic in the Philippines and Taiwan.

Authors:  Donald E Morisky; Shu-Yu Lyu; Lianne A Urada
Journal:  Prospects (Paris)       Date:  2009-12-01
  8 in total
  10 in total

1.  Efficacy of Electroacupuncture Combined with Auricular Point Pressing in Improving Mental Well-Being among Individuals with Heroin Use Disorder: A Randomized Controlled Crossover Trial and Pilot Study.

Authors:  Kai-Chiang Yu; Han-Ting Wei; Shang-Chih Chang; Chung-Hua Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-25       Impact factor: 2.629

2.  A Smartphone Application Supporting Recovery from Heroin Addiction: Perspectives of Patients and Providers in China, Taiwan, and the USA.

Authors:  Marya Schulte; Di Liang; Fei Wu; Yu-Ching Lan; Wening Tsay; Jiang Du; Min Zhao; Xu Li; Yih-Ing Hser
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-04       Impact factor: 4.147

3.  Risk factors for HIV-1 seroconversion among Taiwanese men visiting gay saunas who have sex with men.

Authors:  Yen-Ju Chen; Yu-Ting Lin; Marcelo Chen; Szu-Wei Huang; Su-Fen Lai; Wing-Wai Wong; Hung-Chin Tsai; Yu-Huei Lin; Hsin-Fu Liu; Shu-Yu Lyu; Yi-Ming A Chen
Journal:  BMC Infect Dis       Date:  2011-12-05       Impact factor: 3.090

4.  Molecular Epidemiology of HIV-1 Infection among Men who Have Sex with Men in Taiwan in 2012.

Authors:  Szu-Wei Huang; Sheng-Fan Wang; Ángel E Cowó; Marcelo Chen; Yu-Ting Lin; Chun-Po Hung; Yi-Hsien Chen; Jyh-Yuan Yang; Hung-Jen Tang; Yi-Ming Arthur Chen
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

5.  Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohorts.

Authors:  Yen-Fang Huang; Jyh-Yuan Yang; Kenrad E Nelson; Hsu-Sung Kuo; Chin-Yin Lew-Ting; Chin-Hui Yang; Chang-Hsun Chen; Feng-Yee Chang; Hui-Rong Liu
Journal:  PLoS Med       Date:  2014-04-08       Impact factor: 11.069

6.  Characterization of the Drug Resistance Profiles of Patients Infected with CRF07_BC Using Phenotypic Assay and Ultra-Deep Pyrosequencing.

Authors:  Szu-Wei Huang; Wei-You Li; Wen-Hung Wang; Yu-Ting Lin; Chih-Hung Chou; Marcelo Chen; Hsien-Da Huang; Yen-Hsu Chen; Po-Liang Lu; Sheng-Fan Wang; Shinichi Oka; Yi-Ming Arthur Chen
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

7.  Traditional Chinese medicine-facilitated treatments may relieve anxiety symptoms during drug switching from methadone to buprenorphine/naloxone for treating opioid dependence.

Authors:  Kai-Chiang Yu; Han-Ting Wei; Yuh-Hsiang Yeh; Chung-Hua Hsu
Journal:  BMJ Case Rep       Date:  2017-11-09

8.  Harm reduction policy in Taiwan: toward a comprehensive understanding of its making and effects.

Authors:  Jia-Shin Chen
Journal:  Harm Reduct J       Date:  2016-04-04

9.  Effects of combination approach on harm reduction programs: the Taiwan experience.

Authors:  Ting Lin; Chang-Hsun Chen; Pesus Chou
Journal:  Harm Reduct J       Date:  2016-07-04

10.  Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan.

Authors:  Chia-Wen Li; Chia-Jui Yang; Hsin-Yun Sun; Mao-Song Tsai; Shih-Ping Lin; Te-Yu Lin; Chien-Yu Cheng; Yi-Chien Lee; Yu-Shan Huang; Chun-Eng Liu; Yuan-Ti Lee; Hung-Jen Tang; Ning-Chi Wang; Shu-Hsing Cheng; Wen-Chien Ko; Chien-Ching Hung
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.